Claudia Finamore 1 , Giuliana Baronissi 1 , Silvia Marchianò 2 , Francesco Saverio Di Leva 1 , Adriana Carino 2 , Maria Chiara Monti 3 , Vittorio Limongelli 1 , 4 , Angela Zampella 1 , Stefano Fiorucci 2 , Valentina Sepe 1 , *
16 March 2019
As a cellular bile acid sensor, farnesoid X receptor (FXR) and the membrane G-coupled receptor (GPBAR1) participate in maintaining bile acid, lipid, and glucose homeostasis. To date, several selective and dual agonists have been developed as promising pharmacological approach to metabolic disorders, with most of them possessing an acidic conjugable function that might compromise their pharmacokinetic distribution. Here, guided by docking calculations, nonacidic 6-ethyl cholane derivatives have been prepared. In vitro pharmacological characterization resulted in the identification of bile acid receptor modulators with improved pharmacokinetic properties.